A SUNDERLAND firm is helping to wage the war on cancer.
Onyx Scientific has been appointed by Cancer Research UK to manage several of its drug development projects, and is supporting the charity with the development and production of active pharmaceutical ingredients (API) for use in clinical trials.
The charity initially selected the North-East based chemistry specialist for a project in 2011 and Onyx Scientific is now one of the charity’s preferred providers for API development and GMP synthesis, which has resulted in a greater volume of work being placed with Onyx due to the quality of its work, compliance, communication and ‘can do’ attitude.
Dr Nigel Westwood, drug supply manager at Cancer Research UK, said: “Over the last few years, the team at Onyx Scientific has worked proactively with us on several challenging synthetic chemistry projects and provided exceptional value for money, which has led to us to select them for several new projects based on the company’s competitive costs and ability to deliver on time.
“Having sufficient quantities of API available in a timely manner is critical for our drug development activities.
“Onyx Scientific is a reliable partner that can meet deadlines and deal with complex chemistry in a cost effective manner.”
The firm’s labs on Sunderland Enterprise Park deal with complex chemistry in its early stages and the firm is then able to scale-up production using its commercial manufacturing sites in India.
Commercial director Denise Bowser said: “Our team has developed an excellent partnership with Cancer Research UK so we are delighted to be working with them on such a raft of important projects.
“It is very pleasing that our track-record and reputation in solid state chemistry.”